Settlement and Release Agreement - Theralink (Details Narrative) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares
Series E Preferred Stock [Member]
Business Acquisition [Line Items]
Stock issued during period, shares | shares	24,172
Settlement and Release Agreement [Member]
Business Acquisition [Line Items]
Payment for long lived assets | $	$ 1.1
Notes receivables | $	$ 1.1
Settlement and Release Agreement [Member] | Series E Preferred Stock [Member]
Business Acquisition [Line Items]
Stock issued during period, shares | shares	24,172
Conversion price per share | $ / shares	$ 3.641